Patents by Inventor Renaud G. Seigneuric

Renaud G. Seigneuric has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7960114
    Abstract: The present invention provides methods and compositions for predicting patient responses to cancer treatment using hypoxia gene signatures. These methods can comprise measuring in a biological sample from a patient the levels of gene expression of a group of the genes designated herein. The present invention also provides for microarrays that can detect expression from a group of genes.
    Type: Grant
    Filed: May 1, 2008
    Date of Patent: June 14, 2011
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Renaud G. Seigneuric, Maud H. W. Starmans, Glenn Fung, Balaji Krishnapuram, Dimitry S. A. Nuyten, Arie van Erk, Michael Gaston Magagnin, Kasper M. Rouschop, Sriram Krishnan, R. Bharat Rao, Christoffel Theodorus Anthonius Evelo, Adrian Campbell Begg, Bradly G. Wouters, Philippe Lambin
  • Publication number: 20090130096
    Abstract: The present invention provides methods and compositions for predicting patient responses to cancer treatment using hypoxia gene signatures. These methods can comprise measuring in a biological sample from a patient the levels of gene expression of a group of the genes designated herein. The present invention also provides for microarrays that can detect expression from a group of genes.
    Type: Application
    Filed: May 1, 2008
    Publication date: May 21, 2009
    Applicant: Siemens Medical Solutions USA, Inc.
    Inventors: Renaud G. Seigneuric, Maud H.W. Starmans, Glenn Fung, Balaji Krishnapuram, Dimitry S.A. Nuyten, Arie van Erk, Michael Gaston Magagnin, Kasper M. Rouschop, Sriram Krishnan, R. Bharat Rao, Christoffel Theodorus Anthonius Evelo, Adrian Campbell Begg, Bradly G. Wouters, Philippe Lambin
  • Publication number: 20090006055
    Abstract: A list of biomarkers indicative of patient outcome is reduced. A computer program is applied to a set of biomarkers indicative of a patient outcome (e.g., prognosis, diagnosis, or treatment result). The computer program models the set of biomarkers with a subset of the biomarkers. The subset is identified without labeling based on the patient outcome. Instead, biomarker scores (e.g., sequence score) are used to identify the subset of biomarkers.
    Type: Application
    Filed: June 9, 2008
    Publication date: January 1, 2009
    Applicant: Siemens Medical solutions USA, Inc.
    Inventors: Glenn Fung, Renaud G. Seigneuric, Sriram Krishnan, R. Bharat Rao, Philippe Lambin
  • Publication number: 20080286273
    Abstract: The present invention provides methods and compositions for predicting patient responses to cancer treatment using a proliferation gene signature. These methods can comprise measuring in a biological sample from a patient the levels of gene expression of a group of the genes designated herein. The present invention also provides for microarrays that can detect expression from a group of genes.
    Type: Application
    Filed: May 1, 2008
    Publication date: November 20, 2008
    Applicant: Siemens Medical Solutions USA, Inc.
    Inventors: Maud H.W. Starmans, Balaji Krishnapuram, Renaud G. Seigneuric, Harald Steck, Dimitry S.A. Nuyten, Francesca Meteora Buffa, Adrian Lewellyn Harris, Bradly G. Wouters, Philippe Lambin, R. Bharat Rao, Sriram Krishnan